Bringing cell therapies closer to patients: the role of automation, analytics, and decentralized manufacturing

“For certain indications and types of therapies, I believe autologous cell therapy and decentralized manufacturing can truly increase patient access.”

Jokūbas Leikauskas (Editor, BioInsights) speaks to Therese Choquette (Head of Analytical and Translational Sciences, Tigen Pharma) about autologous cell therapy manufacturing challenges, analytics strategies, decentralized production models, the importance of collaboration, and the role of automation and digitization in improving scalability and patient access.

Please enter your email to access content Read now